U. S. Department of Health and Human Services - Drug Treatments for the Prevention of Migraine Headache: Technical Review 2.3 epub indir internet üzerinden

Drug Treatments for the Prevention of Migraine Headache: Technical Review 2.3

Drug Treatments for the Prevention of Migraine Headache: Technical Review 2.3 adlı kitabı telefonunuzda, bilgisayarınızda veya tabletinizde EPUB biçiminde okumak için "okuyucu" uygulamasını ücretsiz veya satın almanız gerekir - siz karar verin. İşlevsel olarak özgür "okuyucular" nadiren ücretli olanlara yol verir ve bazen onları aşar. Bazen daha yavaş çalışır veya reklam içerir. Ücretli uygulamalar daha güzel görünür, daha az yavaşlar, aynı işlevsellik ile telefonun belleğinde genellikle daha az yer kaplarlar. Veya U. S. Department of Health and Human Services adresinden çevrimiçi olarak Drug Treatments for the Prevention of Migraine Headache: Technical Review 2.3 kitap okumak için bir site bulabilirsiniz. EPUB, kayan bir düzene sahip bir biçimdir, yani kitabın metni, örneğin Drug Treatments for the Prevention of Migraine Headache: Technical Review 2.3, akıllı telefonunuzun veya tabletinizin ekran boyutuna otomatik olarak ayarlanır - manuel olarak ölçeklendirmeniz gerekmez. Son aşamada, biçim bilgisayarlar, akıllı telefonlar ve tabletler tarafından desteklenen 5.2 sürümüne güncellenir. Gutenberg Serbest Kütüphanesi, 2008 yılında Drug Treatments for the Prevention of Migraine Headache: Technical Review 2.3 gibi kitapları ve diğer basılı yayınları ve kitapları dijitalleştirmek ve saklamak için bu biçimi seçti. Yavaş yavaş, 2010'a kadar, daha önce kendi LRF uzantısını (BBeB) kullanan Sony, belgeleri bu biçime dönüştürdü. E-kitapların ve "okuyucuların" artan popülaritesi ile birlikte popülerlik kazanıyor. İlk kez 1999'da ABD'de ortaya çıktı, farklı olarak adlandırıldı - Açık eKitap Yayını (OEB). Geliştirici - Uluslararası Dijital Yayıncılık Forumu, IDPF kısaltması: Uluslararası Dijital Yayıncılık Forumu. 2007 yılında, “forum”, doğrudan “Elektronik Yayıncılık” olan ve tam anlamıyla “Elektronik Yayıncılık” olarak kısaltılan geliştirmenin son versiyonunu tanıttı.


Biçimi seçin
pdf ibook fb2

Elsevier España, S.L.U. Kolektif Independently published Wydawnictwo Nasza Wiedza Fransızca F. A. Davis Elsevier Güneş Tıp Kitabevleri Ankara Nobel Tıp Kitabevleri Türkçe İtalyanca U. S. Department of Health and Human Services Health Formation LAP LAMBERT Academic Publishing İngilizce İspanyolca Lovely Hearts Publishing Almanca
indir okumak internet üzerinden
Yazar Drug Treatments for the Prevention of Migraine Headache: Technical Review 2.3 U. S. Department of Health and Human Services Agency for Health Care Policy and Research U. S. Public Health Service

Migraine is a common and disabling health problem among adult Americans. Surveys from the U.S. and elsewhere suggest that 6% of men and 15% to 17% of women experience migraine headaches. These headaches result in significant disability and work loss; estimated aggregate indirect costs to employers in theU.S. for reduced productivity due to migraine range from $6.5 billion to $17 billion annually. Patterns of medical care for the treatment of migraine are highly variable. A substantial proportion of migraineurs never consult a physician about their headaches. Among those who do seek medical attention, many do not continue with the course of treatment prescribed by their physician, citing the availability of nonprescription medications and negative side effects associated with prescription medications among the reasons for self-treatment. Preventive drug treatments are used by a small percentage of migraineurs -- 3% to 5% of patients in various studies. It is not known whether the patients in these studies who were not using preventive drug therapy had never been offered such treatment or had tried it and found it ineffective or intolerable. A substantial body of high-quality evidence exists describing the effectiveness of various drugs for the prevention of migraine. Synthesis and dissemination of this information may help correct the underuse or misuse of preventive drug treatment strategies for migraine. The objective of this evidence report is to provide a comprehensive review and analysis of published reports of randomized controlled trials (RCTs) and other prospective, comparative clinical trials of drug treatments for the prevention of migraine. The present report does not cover all drugs that may be used for the prevention of migraine, but only those that have been studied in controlled trials among a population of migraineurs

Son kitaplar

İlgili kitaplar

Screening for Hepatitis C Virus Infection in Adults: Comparative Effectiveness Review Number 69


indir bedava
Screening for HIV in Pregnant Women: Systematic Review to Update the U.S. Preventive Services Task Force Recommendation: Evidence Synthesis Number 96


indir bedava
Behavioral Interventions and Counseling to Prevent Child Abuse and Neglect: Systematic Review to Update the U. S. Preventive Services Task Force Recommendation: Evidence Synthesis Number 98


indir bedava
Pharmacology for Rehabilitation Professionals, 2e


indir bedava
P.O.P.T. Psycholinguistisch orientierte Phonologie-Therapie: Therapiehandbuch


indir bedava